Here, we unravelled that the expression of GPR65 was enhanced in inflamed gut mucosa and PB‐CD4+ T cells of active IBD patients and identified that GPR65 could facilitate Th1 and Th17 cell differentiation and participate in the etiopathogenesis of colitis by impeding NUAK2 expression. Here, CD4 is linked to colitis.